Global Thrombectomy Devices Market 2016-2020
About Thrombectomy Devices
Over the years, majority of the minimally invasive cardiovascular surgeries have been increasingly using atherectomy and thrombectomy devices to increase the success rate of surgeries and reduce the procedure and recovery time. Atherectomy devices are primarily used to clear blood vessels that have been occluded by fat accumulation (atherosclerosis plaque). Thrombectomy devices, on the other hand, are used to extract, excise, or disrupt blood clots. They use a variety of methods to safely remove emboli in any part of the body. The global thrombectomy devices market is witnessing continuous technological developments and innovations.
Technavio’s analysts forecast the global thrombectomy devices market to grow at a CAGR of 5.73% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global thrombectomy devices market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of thrombectomy products provided by various vendors in the market.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Thrombectomy Devices Market 2016-2020
Technavio recognizes the following companies as the key players in the global thrombectomy devices market: Boston Scientific, Medtronic, Teleflex, and DePuy Synthes.
Other Prominent Vendors in the market are: Abbott Laboratories, Acandis, AngioDynamics, Argon Medical Devices, Edwards Lifesciences, Minnetronix, NexGen Medical Systems, Penumbra, Reverse Medical, Stryker, Terumo, and Vascular Solutions.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is technological advancements with the advent of laser & UV radiation. With the advent of laser and ultra-violet (UV) radiation technology, the dissolving of blood clots has become easier. The use of laser thrombectomy has eliminated the need for mechanical thrombus removal. Pulsed UV excimer laser light at 380nm frequency can help in the vaporization of thrombus and suppressing the aggregation of platelets.”
According to the report, one of the major drivers for this market is rise in prevalence of cardiovascular and cerebrovascular diseases. the rise in prevalent cases of cardiovascular and cerebrovascular diseases is driving the market growth, with the increased use of thrombectomy devices for the removal of blood clots. Some of the common cardiovascular diseases where blood clots occur are coronary heart diseases and peripheral vascular diseases.
Further, the report states that one of the major factors hindering the growth of this market is lack of product differentiation. Vendors are currently finding it difficult to remain competitive in the market because of the lack of product differentiation. Since the features and functionalities of various products are similar in nature, most healthcare centers and surgeons tend to opt for products based on familiarity with a specific brand name. Hence, it is critical for manufacturers to develop a technologically-advanced product line to achieve product differentiation.
Boston Scientific, Medtronic, Teleflex, DePuy Synthes, Abbott Laboratories, Acandis, AngioDynamics, Argon Medical Devices, Edwards Lifesciences, Minnetronix, NexGen Medical Systems, Penumbra, Reverse Medical, Stryker, Terumo, Vascular Solutions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook